COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins

N. S. Stuleva; A. L. Mishchenko

Obstetrics, Gynecology and Reproduction
Akuserstvo, Ginekologia i Reprodukcia

eng | рус

User

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)

Obstetrics, Gynecology and Reproduction

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Stuleva N.S., Mishchenko A.L. COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins. Obstetrics, Gynecology and Reproduction. 2021;15(3):225-227. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.219

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)

Popular articles

Editor-in-Chief

Makatsariya A.D.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

N. S. Stuleva
Sechenov University; Center of Reproductive Medicine and Genetics «Nova Clinic»
Russian Federation

Nadezhda S. Stuleva – MD, PhD, Associate Professor, Department of Obstetrics and Gynecology, Filatov Clinical Institute of Children’s Health, Sechenov University; Obstetrician-Gynecologist, Center of Reproductive Medicine and Genetics «Nova Clinic»

2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991

20 Lobachevsky Str., Moscow 119415

A. L. Mishchenko
Sechenov University
Russian Federation

Alexander L. Mishchenko – MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology, Filatov Clinical Institute of Children’s Health

2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991

Notifications

Username
Password
	Remember me

User

Obstetrics, Gynecology and Reproduction

For citations:

Cookies policy